Guardant Health GH 深 滬
等待開盤 03-26 09:30:00 美东时间
86.58
+2.990
+3.58%
華盛通- 最 高89.26
- 今 開85.00
- 成交量 214.93万股
- 最 低 84.51
- 昨 收 83.59
- 總市值 113.57亿
- 52周最高 120.74
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 36.36
- 委 比 -91.00%
- 總股本 1.31亿
- 歷史最高 181.07
- 量 比 1.24
- 振 幅 5.68%
- 歷史最低 15.81
- 每 手 1
- 風險率 25.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Verana Health and Guardant Health partner to combine EHR and clinicogenomic data for oncology research
Verana Health and Guardant Health partner to combine EHR and clinicogenomic data for oncology research Guardant Health and Verana Health entered a partnership to combine Verana’s curated EHR datasets with Guardant’s clinicogenomic testing data for biopharmaceutical research. The collaboration is int
03-24 21:15
Guardant Health Highlights Poll Results Showing Overwhelming Majority Of Respondents Believe Colorectal Screening Products Should Be Covered With No Co-Pay
The survey showed an overwhelming majority of Americans of screening-eligible age (92%) believe that blood-based colorectal cancer screening should be covered with no co-pay similar to Medicare Part B and VA Community
03-13 20:18
Guardant Health survey shows 92% support no-copay coverage for colorectal cancer blood tests
Guardant Health survey shows 92% support no-copay coverage for colorectal cancer blood tests Guardant reported results from a Harris Poll survey of 1,189 U.S. adults aged 45 and older on colorectal cancer screening. The survey found that 92% of screening-eligible adults said blood-based colorectal c
03-13 20:09
Braidwell, Karnal and Kreiter's AI healthcare fund, surged 28% last year
Braidwell, Karnal and Kreiter's AI healthcare fund, surged 28% last year Braidwell generated 28% gross return in 2025 Braidwell's investments include Guardant Health, Alphatec, and Caris Life Sciences Firm launched in 2022 by Alex Karnal and Brian Kreiter, raising $3.5 billion By Anirban Sen NEW YOR
03-11 18:00
艾迪康旗下上海锦测实验室通过CAP复评审，携手Guardant Health共推...
近期，艾迪康旗下上海锦测医学检验所有限公司正式通过美国病理学家协会（CAP）复评审。此次CAP复评审的顺利通过，标志着该实验室在样本处理、实验流程、数据分析、质...
03-09 09:50
Patrick Dempsey Partners With Guardant Health to Promote Shield Colorectal Cancer Screening Test
Patrick Dempsey Partners With Guardant Health to Promote Shield Colorectal Cancer Screening Test Guardant Health Inc. has partnered with actor and cancer advocate Patrick Dempsey to raise awareness of colorectal cancer screening and promote its FDA-approved Shield blood test. The collaboration will
03-03 20:04
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies
U.S. RESEARCH ROUNDUP-Dollar General, Keysight Technologies, Teledyne Technologies Feb 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Dollar General, Keysight Technologies and Teledyne Technologies, on Tuesday. HIGHL
02-24 15:56
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
Guardant Health acquires Israeli healthtech MetaSight for up to $150M
Guardant Health (GH) has acquired MetaSight Diagnostics for $59M upfront and up to $90M in milestone payments. The Israeli startup is known for developing early cancer and liver fibrosis detection tes...
02-20 23:41
